The significant price of healthcare in the United States (US) and in other places can limit the flexibility of patients to afford to pay for and adhere to remedy selections. Thus, through their respective associations/bodies, suppliers can champion plan proposals that advocate a cap on out-of-pocket investing on all prescription medications based o